From cold reason to emotion: a shift in perspective
For decades, neuroscience focused primarily on cognition: perception, attention, memory, and the so-called executive functions. But in recent years, a sister discipline has gained prominence: affective neuroscience, which is dedicated to understanding how the brain generates and regulates emotions. This is neither a minor field nor an appendix. No human decision, however calculated we believe it to be, occurs outside of an emotional context: our mood colors what we perceive and what we choose, and conversely, what we learn shapes our moral and social reactions.
Neurologist Antonio Damasio popularized this idea in Descartes’ Error: far from hindering reason, emotions are an essential part of how we make decisions. What for centuries was presented as a battle between the head and the heart turns out, in light of the evidence, to be a constant collaboration.
How to measure an emotion in the lab
To study this, researchers rely on what is known as affective cognition: the point where emotion and cognition integrate to produce behavior. For example, they evaluate the ability to recognize the valence of a stimulus (whether something is pleasant or unpleasant) or to label the emotional expressions of others. Standard tasks show volunteers faces expressing basic emotions and record the response via electroencephalogram or functional magnetic resonance imaging, observing the brain “live” as it works.
One of the most studied capabilities is theory of mind: the ability to attribute internal states, intentions, and feelings to other people. It is what allows us to be moved by a film, hold a look of complicity, or “feel with” someone who is crying. This capacity is altered in conditions like schizophrenia and is at the root of autism spectrum disorders. To measure it, researchers use, among other tests, the Reading the Mind in the Eyes Test, originally designed in the context of autism: 36 images showing only a person’s eyes, from which the subject must choose the emotion being expressed.
What substances do to emotional processing
The study of the acute effects of drugs traditionally focused on the cognitive: whether they slow reaction times, affect working memory, hinder sustained attention, or rigidify behavior. More recently, interest has emerged regarding their impact on the emotional. The logic is twofold: on one hand, to understand what these substances do; on the other, to use those alterations as a window to understand which brain areas govern each emotional process. Here, we are particularly interested in classic hallucinogens and compounds called entactogens or empathogens, with MDMA being the most studied example.
First experiment: MDMA “turns off” the fear of others
An initial controlled study evaluated the effect of MDMA on prosocial behavior and the recognition of emotional states in others. Twenty-one volunteers received four oral treatments in sessions spaced one week apart—two different doses of MDMA, one of methamphetamine, and a placebo—under a randomized, double-blind design: neither the subjects nor the researchers knew what was administered each day. Participants rated their state on visual analog scales (“sociable,” “confused,” “lonely,” etc.) and completed facial and auditory emotional recognition tests. In the facial test, faces started with a neutral expression and gradually mutated toward anger, fear, joy, or sadness.
The most striking result was not the expected increase in “affect” and “friendliness” scales, but something more specific: the higher dose of MDMA robustly reduced the ability to recognize expressions of fear, without altering the recognition of other emotions. The substance has a reputation for being prosocial because it facilitates communication and dissolves social anxiety; this finding suggests a concrete mechanism behind that reputation: if we stop picking up threat signals in another person’s face—and fear is the quintessential threatening signal—social interaction becomes, literally, less dangerous in the eyes of the brain. Interestingly, methamphetamine also increased sociability, and in this sample, the Reading the Mind in the Eyes Test showed no differences compared to the placebo.
Brain imaging: amygdala down, reward up
The same group investigated the basis of this effect using neuroimaging. Under a high dose of MDMA, the amygdala—the structure that lights up in the face of a threat—attenuated its response to angry faces, while the striatum—linked to reward and pleasure—increased its activity in response to happy faces. The pattern is consistent with what was observed in behavior: the substance seems to partially disconnect the alarm in the face of the negative and, at the same time, intensify the pleasure produced by positive connection with other people. It is not just that people feel comfortable chatting and smiling; there is a neurobiological correlate to that bias.
Confirmation in a larger sample
A third study revisited the Reading the Mind in the Eyes Test with a larger group—48 people, half men and half women. The methodological detail matters: often, the absence of results does not mean an absence of effect, but rather a sample too small to detect it. With more participants, differences did appear: MDMA improved the reading of positive mental states (such as a friendly gaze) and worsened the reading of negative ones (such as hostility), without affecting the decoding of neutral states. The same bias, again, through two different paths.
Critical reading
It is advisable to read these findings with caution. These are laboratory studies with small samples, healthy volunteers, and controlled doses under conditions that have nothing to do with recreational use in a noisy environment, with substances of unknown purity and frequent mixing. What is observed is an acute perceptual bias, not a stable improvement in empathy or proof of safety.
That same bias has an uncomfortable side: a substance that reduces the detection of fear and hostility can also attenuate legitimate alarm signals—discomfort, rejection, real danger—in contexts where picking them up provides protection. The feeling of closeness and trust may not correspond to the situation. Furthermore, MDMA is not without risks: hyperthermia, hyponatremia due to excessive water consumption, dangerous interactions with other drugs (especially serotonergic antidepressants), and emotional hangovers in the following days are well-documented issues. The scientific interest of these experiments—including clinical research on MDMA for post-traumatic stress disorder—is not equivalent to an endorsement of use outside of a controlled framework.
The original sources for this information are articles published in peer-reviewed journals on emotional recognition, neuroimaging, and empathy under MDMA. Those who wish to delve deeper can search for these terms in scientific databases like PubMed, always checking sample sizes and experimental conditions before generalizing.
